Indobufen

Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]

Indobufen
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.058.496
Chemical and physical data
FormulaC18H17NO3
Molar mass295.338 g·mol−1
3D model (JSmol)
SMILES
  • O=C(O)C(c1ccc(cc1)N3C(=O)c2ccccc2C3)CC
InChI
  • InChI=1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) N
  • Key:AYDXAULLCROVIT-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

References

  1. The Merck Index (12th ed.). p. 4991.
  2. Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, et al. (January 2006). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–26. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.